CC
RVMD icon

Chicago Capital’s Revolution Medicines RVMD Stock Holding History

Chicago Capital’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$47.2M Buy
+251,847
New +$36.8M 1.14% 29

Other funds holding RVMD

Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
HP
HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return
TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
Asset Management One
Asset Management One Tokyo, Japan $39B AUM 37.51% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
APM
a16z Perennial Management Menlo Park, California $1.24B AUM 7.36% 1-Year Est. Return
WPC
Wedmont Private Capital West Chester, Pennsylvania $3.65B AUM 26.64% 1-Year Est. Return
II
IFM Investors Melbourne, Australia $15.1B AUM 40.57% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return

Chicago Capital's RVMD Position: Q2 2026 in Review

Chicago Capital opened a new position in Revolution Medicines (RVMD) in Q2 2026: 251,847 shares worth $47.2M. The stake represents 1.14% of the portfolio and ranks #29 among its holdings.

154 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Chicago Capital held 251,847 shares of Revolution Medicines worth $47.2M as of Q2 2026.
  • Revolution Medicines was a new Chicago Capital position in Q2 2026.
  • Revolution Medicines made up 1.14% of Chicago Capital's portfolio in Q2 2026, its #29 holding.
  • 154 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Chicago Capital's 13F filing for Q2 2026, filed 28 Jul 2026.